Go Pro
NASDAQ:PPH

VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News

VanEck Pharmaceutical ETF logo
$110.40 0.00 (0.00%)
As of 07/31/2026 04:00 PM Eastern

About VanEck Pharmaceutical ETF (NASDAQ:PPH)

Advanced

Key Stats

Today's Range
$109.12
$110.62
50-Day Range
$101.55
$113.57
52-Week Range
$81.74
$114.57
Volume
174,168 shs
Average Volume
320,915 shs
Market Capitalization
$948.34 million
Assets Under Management
$925.60 million
Dividend Yield
1.97%
Net Expense Ratio
0.36%
Aggregate Rating
Moderate Buy

ETF Overview

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

VanEck Pharmaceutical ETF Expenses

TypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.55%0.57%0.54%0.53%
Other Expenses0.01%0.52%0.53%0.39%0.54%
Total Expense0.36%0.76%0.75%0.69%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.41%-0.68%
Net Expense0.36%0.58%0.63%0.61%0.60%
Receive PPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PPH ETF News Headlines

VanEck Pharmaceutical ETF
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
See More Headlines

PPH ETF - Frequently Asked Questions

VanEck Pharmaceutical ETF's stock was trading at $103.17 at the beginning of 2026. Since then, PPH stock has increased by 7.0% and is now trading at $110.40.

VanEck Pharmaceutical ETF's top institutional investors include Adamsbrown Wealth Consultants LLC (1.76%), Fluent Financial LLC (0.45%), AAFMAA Wealth Management & Trust LLC (0.28%) and Avior Wealth Management LLC (0.14%).

Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Pharmaceutical ETF investors own include Waste Connections (WCN), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
Van Eck
Fund Name
VanEck Pharmaceutical ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:PPH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
MVIS US Listed Pharmaceutical 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
26

Fund Statistics

Assets Under Management
$925.60 million
Average Daily Volume
$240.64 thousand
Discount/Premium
0.05%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
IMC

Options

Optionable
N/A
Short Interest
2,834,538 shs

Miscellaneous

Beta
0.46
Creation Unit
50,000
Creation Fee
$500.00
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Top 10 PPH Holdings

PPH Sector Exposure

PPH Industry Exposure


This page (NASDAQ:PPH) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners